Ahmed Attia Ali

Dr. Ahmed Attia Ali

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2016 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
MBMax Brown
Max Brown
NSNatalie Strudwick
Natalie Strudwick
MSMonika Suwara
Monika Suwara
LSLouise K. Sutcliffe
Louise K. Sutcliffe
AMAdina D. Mihai
Adina D. Mihai
Martin SchröderMartin Schröder
Martin Schröder
Accumulation of unfolded proteins in the endoplasmic reticulum (ER) activates the unfolded protein response (UPR). In mammalian cells, UPR signals generated by several ER-membrane-resident proteins, including the bifunctional protein kinase endoribonuclease IRE1α, control cell survival and the decision to execute apoptosis. Processing of XBP1 mRNA by the RNase domain of IRE1α promotes survival of ER stress, whereas activation of the mitogen-activated protein kinase JNK family by IRE1α late in the ER stress response promotes apoptosis. Here, we show that activation of JNK in the ER stress response precedes activation of XBP1. This activation of JNK is dependent on IRE1α and TRAF2 and coincides with JNK-dependent induction of expression of several antiapoptotic genes, including cIap1 (also known as Birc2), cIap2 (also known as Birc3), Xiap and Birc6. ER-stressed Jnk1−/− Jnk2−/− (Mapk8−/− Mapk9−/−) mouse embryonic fibroblasts (MEFs) display more pronounced mitochondrial permeability transition and increased caspase 3/7 activity compared to wild-type MEFs. Caspase 3/7 activity is also elevated in ER-stressed cIap1−/− cIap2−/− and Xiap−/− MEFs. These observations suggest that JNK-dependent transcriptional induction of several inhibitors of apoptosis contributes to inhibiting apoptosis early in the ER stress response.

1 February 2004 in Bioresource Technology
Verified
Journal Article
Closed access
AFAfaf S. Fahmy
Afaf S. Fahmy
AAAhmed A. Ali
Ahmed A. Ali
AAAhmed Attia Ali
Ahmed Attia Ali

1 January 2011
Verified
Book Chapter
Closed access
DCDavid J. Cox
David J. Cox
NSNatalie Strudwick
Natalie Strudwick
AAAhmed Attia Ali
Ahmed Attia Ali
APAdrienne W. Paton
Adrienne W. Paton
JPJames C. Paton
James C. Paton
MSMartin Schröder
Martin Schröder

1 December 2015 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
AHA.E. El Hakim
A.E. El Hakim
WSW.H. Salama
W.H. Salama
MHMohamed Belal Hamed
Mohamed Belal Hamed
AAAhmed Attia Ali
Ahmed Attia Ali
NIN.M. Ibrahim
N.M. Ibrahim
Two l-amino acid oxidase enzyme isoforms, Cc-LAAOI and Cc-LAAOII were purified to apparent homogeneity from Cerastes cerastes venom in a sequential two-step chromatographic protocol including; gel filtration and anion exchange chromatography. The native molecular weights of the isoforms were 115 kDa as determined by gel filtration on calibrated Sephacryl S-200 column, while the monomeric molecular weights of the enzymes were, 60, 56 kDa and 60, 53 kDa for LAAOI and LAAOII, respectively. The tryptic peptides of the two isoforms share high sequence homology with other snake venom l-amino acid oxidases. The optimal pH and temperature values of Cc-LAAOI and Cc-LAAOII were 7.8, 50 °C and 7, 60 °C, respectively. The two isoenzymes were thermally stable up to 70 °C. The K m and V max values were 0.67 mM, 0.135 μmol/min for LAAOI and 0.82 mM, 0.087 μmol/min for LAAOII. Both isoenzymes displayed high catalytic preference to long-chain, hydrophobic and aromatic amino acids. The Mn2 + ion markedly increased the LAAO activity for both purified isoforms, while Na+, K+, Ca2 +, Mg2 + and Ba2 + ions showed a non-significant increase in the enzymatic activity of both isoforms. Furthermore, Zn2 +, Ni2 +, Co2 +, Cu2 + and AL3 + ions markedly inhibited the LAAOI and LAAOII activities. l-Cysteine and reduced glutathione completely inhibited the LAAO activity of both isoenzymes, whereas, β-mercaptoethanol, O-phenanthroline and PMSF completely inhibited the enzymatic activity of LAAOII. Furthermore, iodoacitic acid inhibited the enzymatic activity of LAAOII by 46% and had no effect on the LAAOI activity.

1 August 2017 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
MAMichael C. Armstrong
Michael C. Armstrong
SŠSergej Šestak
Sergej Šestak
AAAhmed Attia Ali
Ahmed Attia Ali
HSHanan A. M. Sagini
Hanan A. M. Sagini
MBMax Brown
Max Brown
Martin SchröderMartin Schröder
Martin Schröder
The bifunctional protein kinase-endoribonuclease Ire1 initiates splicing of the mRNA for the transcription factor Hac1 when unfolded proteins accumulate in the endoplasmic reticulum. Activation of Saccharomyces cerevisiae Ire1 coincides with autophosphorylation of its activation loop at S840, S841, T844, and S850. Mass spectrometric analysis of Ire1 expressed in Escherichia coli identified S837 as another potential phosphorylation site in vivo. Mutation of all five potential phosphorylation sites in the activation loop decreased, but did not completely abolish, splicing of HAC1 mRNA, induction of KAR2 and PDI1 mRNAs, and expression of a β-galactosidase reporter activated by Hac1i. Phosphorylation site mutants survive low levels of endoplasmic reticulum stress better than IRE1 deletions strains. In vivo clustering and inactivation of Ire1 are not affected by phosphorylation site mutants. Mutation of D836 to alanine in the activation loop of phosphorylation site mutants nearly completely abolished HAC1 splicing, induction of KAR2, PDI1, and β-galactosidase reporters, and survival of ER stress, but it had no effect on clustering of Ire1. By itself, the D836A mutation does not confer a phenotype. These data argue that D836 can partially substitute for activation loop phosphorylation in activation of the endoribonuclease domain of Ire1.

31 December 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
Ashraf TabllAshraf Tabll
Ashraf Tabll
SSSAYED SARTAJ SOHRAB
SAYED SARTAJ SOHRAB
AAAhmed Attia Ali
Ahmed Attia Ali
APAna Petrovic
Ana Petrovic
SSSabina Steiner Srdarevic
Sabina Steiner Srdarevic
MSMartina Smolic
Martina Smolic
Developing a safe and effective vaccine against the hepatitis C virus (HCV) remains a top priority for global health. Despite recent advances in antiviral therapies, the high cost and limited accessibility of these treatments impede their widespread application, particularly in resource-limited settings. Therefore, the development of the HCV vaccine remains a necessity. This review article analyzes the current technologies, future prospects, strategies, HCV genomic targets, and the governmental role in HCV vaccine development. We discuss the current epidemiological landscape of HCV infection and the potential of HCV structural and non-structural protein antigens as vaccine targets. In addition, the involvement of government agencies and policymakers in supporting and facilitating the development of HCV vaccines is emphasized. We explore how vaccine development regulatory channels and frameworks affect research goals, funding, and public health policy. The significance of international and public-private partnerships in accelerating the development of an HCV vaccine is examined. Finally, the future directions for developing an HCV vaccine are discussed. In conclusion, the review highlights the urgent need for a preventive vaccine to fight the global HCV disease and the significance of collaborative efforts between scientists, politicians, and public health organizations to reach this important public health goal.